Ensuring there is an appropriate global PV support and oversight framework for the Americas region of affiliates across all CSL business units (Behring, Seqirus, and Vifor) in complement to the overarching GSPV strategy and objectives in partnership with all GSPV functions. Responsible for senior stakeholder management across the CSL enterprise including but not limited to those in Commercial, Medical, Regulatory Affairs, and Quality.

Creating and maintaining the strategic and operational framework for product safety management, communication, and governance in the affiliate network for all CSL business units.• Liaise with local affiliates to implement process for oversight of Hemgenix® aRMMs for global launch.• Ensures standardization and monitoring of safety signals and other safety relevant information. • Completed short-term international assignment in Zürich, Switzerland supporting the CSL Vifor Global Drug Safety integration

Improving cross-functional processes and spearheading innovation for the Global Clinical Safety & Pharmacovigilance dept. within CSL Behring R&D.• Project managed the PV integration of Vifor Global Drug Safety. Based in CSL Vifor Zürich office February to May 2023. • Implement solutions to increase efficiency and drive down cost of adverse event reporting.• Supported Sr. VP of the PV dept. with effective decision-making, project management, and execution of strategic initiatives across his Leadership Team.• Execution of PV integrations (e.g. Vitaeris, Etranadez, Seqirus Regions, & Vifor), acting as a central driver of value, conflict resolution, and project management.• Facilitated the development of the strategic Automation Roadmap for PV Operations.• Project managed both the NLP for MedDRA Coding PoC and Pilot for Case Management.• Received "Impact Award" for collaborating with IT to co-create CSL's RPA Center of Excellence.• Managed team of RPA developers and launched 3 GxP validated bots into production environment.• Presented at various internal and external global conferences on CSL’s PV automation journey.• Managed & mentored multiple Drexel University co-ops and fostered their personal development.

Recipient of the 2017 Teva President's Club AwardCompleted TMAC Master Black Belt training, December 2, 2016Teva Certified Black Belt, April 25, 2016Teva Certified Black Belt (Sr. Manager) within the Continuous Improvement Dept. Leading multiple Lean Six Sigma projects and process mappings across Teva North America Specialty Medicines to improve processes, decrease costs, and/or increase revenue.

• Developed tactics and strategies for the post-launch of Quartette®- Analyzed sales & Rx data to refine forecasting and assist with supply chain management- Planed, monitored, and managed marketing budgets for the brand- Performed U.S. market research; interviewing HCPs and patients- Rode with Sales Reps. across the country to gather insights and knowledge of the field• On December 2, 2013 was assigned as the lead brand manager for Quartette® and any future OC product launches.- Developed, implemented, and coordinated appropriate business plans and marketing activities to ensure quantitative and qualitative objectives were met- Worked with creative agencies on promotional pieces for in-line and pre-launch products- Managed multiple vendors at a time to align with goals of the brand

Part-time mentorship within Teva’s Global Medicines Insights Group.• Attended the 2013 Teva Marketing Research & Forecasting Summit and learned the newest methodologies that my Teva colleagues are utilizing to enhance insights and make business recommendations while increasing cost-efficiencies.• Observed several primary market research studies of HCPs and consumers across different therapeutic areas.• Participated in discussions with internal customers regarding the best approach and availability of market research resources to answer key business questions.• Leveraged clinical experience to provide insights and knowledge pertaining to the worldwide clinical trial process.• Provided executive summaries on global market size assessments and growth drivers from syndicated reports on therapeutic areas that are of interest to business development.

• Analyze Conflict Management - Search query analysis to drive negative keyword expansion and campaign structure refinement.• Campaign Maximization and Optimization - Campaign asset development including keyword and ad copy building. - Keyword level bid optimization to target campaign segment-specific efficiency goals. - Developed macros and analysis tool building to streamline spreadsheet manipulation.• Prepared and executed strategy for Enhanced Campaign account transitions

On October 14, 2011 Cephalon, Inc. was acquired by Teva, Ltd.• Provided analytical expertise for optimizing drug stability via Design of Experiments.• Detailed analysis of experiments using JMP statistical software.• Managed a student intern during summer 2012.In 2010 was reassigned to a two person team in charge of method development of biologics.• Bioanalytical support and method development provided to formulation development for antibodies, polypeptides, and other large molecules.• Provided method development expertise for bioanalytical HPLC methods such as HIC, SEC, and IEX.• Developed methods for capillary electrophoresis (cSDS & cIEF).• Provided analytical support for biologic testing using the following techniques: Viscometry, SDS-PAGE, UV concentration, and Raman.• Performed protein diafiltration and concentration techniques along with fraction collection of isoforms.• Performed aggregate analysis using DLS in conjunction with SEC and SDS-PAGE.

Worked within Analytical Development for the Chromatography Group and performed HPLC assays of various dosage forms. • Managed a student intern during summer 2010.• Provided method development & validation of new HPLC stability indicating methods for current & newly discovered API’s & formulations for transfer to QC. • Performed forced degradation studies in accordance with ICH guidelines.• Conducted multiple reconstitution/admixture studies for Treanda®. • Experienced working with injectables, oral liquid, and solid dosage formulations.• Used solid-state techniques such as Raman, particle size, XRPD, microscopy, Karl Fischer, and viscometry.• Experienced working in a GLP environment for analytical support of toxicology samples formulated in suspensions and in DMSO solutions. • Provided analytical support to the formulation development group and to quality control for OOS/OOT investigations and for IND/NDA filings.• Methods, development reports, and SOPs written routinely.• Familiar with cGxPs.

Hired as a full-time permanent employee within Analytical Development working for the Chromatography Group. • Provided analytical method development and support for extended release formulations.• Attended several training courses to build expertise in HPLC method development, API solid-state analysis & viscosity analysis.

Summer Internship in a pharmaceutical formulations lab working in the Drug Discovery Support group. • Performed research on particle size reduction of API using physical methods with dissolution, DSC, HPLC, optical microscopy and particle size measurement (micro and nano) for analysis. • Presented a PowerPoint presentation to colleagues and wrote an internal report on the research project. • Received Drug Development Achievement Award.